コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 lucose-6-phosphatase and phosphoenolpyruvate carboxykinase.
2 ed expression of hepatic phosphoenolpyruvate carboxykinase.
3 lucose-6-phosphatase and phosphoenolpyruvate carboxykinase.
4 y gluconeogenetic enzyme phosphoenolpyruvate carboxykinase.
5 glucose-6-phosphtase and phosphoenolpyruvate carboxykinase.
6 lucose-6-phosphatase and phosphoenolpyruvate carboxykinase.
7 nd the cytosolic form of phosphoenolpyruvate carboxykinase.
8 lucose-6-phosphatase and phosphoenolpyruvate carboxykinase.
9 of the gene that encodes phosphoenolpyruvate carboxykinase 1 (a protein involved in gluconeogenesis)
10 ted that the activity of phosphoenolpyruvate carboxykinase 1 (AT4G37870), a key enzyme in gluconeogen
11 coneogenic genes such as phosphoenolpyruvate carboxykinase 1 (Pck-1) and glucose 6-phosphatase (G6Pas
12 ey gluconeogenic enzymes phosphoenolpyruvate carboxykinase 1 (PCK1) and glucose-6 phosphatase (G6PC)
13 for transcription of the phosphoenolpyruvate carboxykinase 1 (PCK1) gene to increase liver gluconeoge
14 6-phosphatase (G6PC) and phosphoenolpyruvate carboxykinase 1 (PCK1) has negative consequences for blo
15 via genetic knockdown of phosphoenolpyruvate carboxykinase 1 (Pck1) prevented fatty acid-induced rise
17 investigate the role of phosphoenolpyruvate carboxykinase 1 (PCK1), an enzyme involved in gluconeoge
18 en phosphorylase (PYGL), phosphoenolpyruvate carboxykinase 1 (PCK1), and the glucose-6-phosphatase ca
19 phosphorylates cytosolic phosphoenolpyruvate carboxykinase 1 (PCK1), the rate-limiting enzyme in gluc
20 hrough overexpression of phosphoenolpyruvate carboxykinase 1 (PCK1), which bolstered effector functio
21 ase 2 (SGK2) to activate phosphoenolpyruvate carboxykinase 1 (PEPCK1) and glucose-6-phosphatase (G6Pa
22 rum glucagon and hepatic phosphoenolpyruvate carboxykinase 1 (PEPCK1) expression, without affecting i
25 R effects on fetal liver phosphoenolpyruvate carboxykinase 1 (protein, PEPCK1; gene, PCK1 orthologous
26 his treatment normalizes phosphoenolpyruvate carboxykinase 1 contents without affecting glycogen leve
27 ced transcription of the phosphoenolpyruvate carboxykinase 1 gene was strikingly increased in cryptoc
28 decreased the levels of phosphoenolpyruvate carboxykinase 1 mRNA in mice but not in Car(-/-) mice.
29 response element in the phosphoenolpyruvate carboxykinase 1 promoter in a hormone-dependent manner,
30 the gluconeogenic enzyme phosphoenolpyruvate carboxykinase 1 were increased in hPXR mice compared wit
31 ncreased mRNA levels for phosphoenolpyruvate carboxykinase 1, argininosuccinate synthase 1, sodium/gl
32 zyme in gluconeogenesis, phosphoenolpyruvate carboxykinase 1, is regulated through reversible acetyla
33 f metabolism transcripts Phosphoenolpyruvate carboxykinase-1, 4-Hydroxyphenylpyruvate dioxygenase, Di
34 y bound to mitochondrial phosphoenolpyruvate carboxykinase 2 ( Pck2) mRNA and increased its transcrip
35 arboxykinase (PEPCK) and phosphoenolpyruvate carboxykinase 2 (PCK2) to reprogram anabolic metabolism
36 reased the expression of phosphoenolpyruvate carboxykinase 2 (PEPCK), glucose-6-phosphatase (G6Pase)
37 ess with an inhibitor of phosphoenolpyruvate carboxykinase (3-mercaptopicolinic acid), metastatic, ER
38 patic mRNA expression of phosphoenolpyruvate carboxykinase, a well known rate-limiting enzyme of live
39 voprotein subunit alpha, phosphoenolpyruvate carboxykinase, aconitate hydratase, branched-chain alpha
40 mutant lacked detectable phosphoenolpyruvate carboxykinase activity and grew poorly in the absence of
43 ly related IRSs from the phosphoenolpyruvate carboxykinase and apolipoprotein CIII genes also are eff
44 rPDK4 gene but also with phosphoenolpyruvate carboxykinase and CPT-1a (carnitine palmitoyltransferase
45 on in KO mice stimulated phosphoenolpyruvate carboxykinase and G6Pase mRNA abundance and raised the b
46 he gluconeogenic enzymes phosphoenolpyruvate carboxykinase and G6Pase mRNAs was reduced by more than
47 ressed mRNA abundance of phosphoenolpyruvate carboxykinase and glucose-6-phosphatase (G6Pase) in KO m
48 the cytosolic isoform of phosphoenolpyruvate carboxykinase and glucose-6-phosphatase were reduced, tr
49 gluconeogenesis such as phosphoenolpyruvate carboxykinase and glucose-6-phosphatase when HNF4alpha i
50 l gluconeogenic enzymes, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase, above the level
51 gluconeogenic, including phosphoenolpyruvate carboxykinase and glucose-6-phosphatase, and also activa
54 lved in gluconeogenesis (phosphoenolpyruvate carboxykinase and glycogen synthase) and sinusoidal bile
55 We show that lack of phosphoenolpyruvate carboxykinase and isocitrate lyase, two enzymes necessar
56 ynamics and catalysis in phosphoenolpyruvate carboxykinase and other enzymes in which the transition
57 ally, we determined that phosphoenolpyruvate carboxykinase and synthase do not carry flux at these ex
58 of two key genes: PEPCK (phosphoenolpyruvate carboxykinase) and SREBP-1c (sterol regulatory element-b
59 r gluconeogenic enzymes, phosphoenolpyruvate carboxykinase, and fructose-1,6-bisphosphatase was also
60 liver glycogen synthase, phosphoenolpyruvate carboxykinase, and glucose-6-phosphatase remained at nor
61 element-binding protein, phoshoenolpyruvate carboxykinase, and peroxisome proliferator-activated rec
62 er-type pyruvate kinase, phosphoenolpyruvate carboxykinase, and type I deiodinase but not hydroxymeth
64 d gluconeogenic enzymes (phosphoenolpyruvate carboxykinase), as well as the diet-responsive type I de
65 lucose-6 phosphatase and phosphoenolpyruvate carboxykinase, as well as a marked increase in hepatic n
67 The pckA gene, encoding phosphoenolpyruvate carboxykinase, catalyzes the reversible decarboxylation
68 lation (anaplerosis) and phosphoenolpyruvate carboxykinase (cataplerosis) and decreased flux through
69 of the cytosolic form of phosphoenolpyruvate carboxykinase caused a marked extension of the life span
70 etate (OAA) by cytosolic phosphoenolpyruvate carboxykinase (cPEPCK) were investigated by the systemat
72 Transcripts encoding phosphoenolpyruvate carboxykinase did not appear to be regulated by pCO(2) i
73 ctose bisphosphatase and phosphoenolpyruvate carboxykinase (encoded by ICL1, MAS1, TAL1, FBP1, and PC
75 se activity and increased phosphenolpyruvate carboxykinase expression and correlated with increased p
76 In addition, increased phosphoenolpyruvate carboxykinase expression in DHet mouse liver was reverse
77 the observed increase in phosphoenolpyruvate carboxykinase expression, type IA fibers, and mitochondr
78 etabolic genes including phosphoenolpyruvate carboxykinase, fatty acid synthase, carnitine palmitoylt
79 s glucose-6-phosphatase, phosphoenolpyruvate carboxykinase, fructose-1,6-phosphatase, respectively, a
80 tes expression of PEPCK (phosphoenolpyruvate carboxykinase), G6P (glucose-6-phosphatase), and certain
81 (IRS-1), and it reduces phosphoenolpyruvate carboxykinase gene expression in a phosphoinositide 3-ki
83 ere also observed in the phosphoenolpyruvate carboxykinase gene that contains a functional HNF-4-bind
84 he complete induction of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids.
85 ion of hormone-activated phosphoenolpyruvate carboxykinase gene transcription by glucose was not affe
86 for insulin (in the rat phosphoenolpyruvate carboxykinase gene), glucocorticoids, cAMP, and phorbol
87 ing the promoter for the phosphoenolpyruvate carboxykinase gene, conditional, tissue-specific express
88 nd hepatic expression of phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, and fatty acid syn
89 c gluconeogenic enzymes, phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, and fructose 1,6-b
90 L-iNOS-Tg mice, whereas phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, and proliferator-a
91 ession of genes encoding phosphoenolpyruvate carboxykinase, glycogen synthase, and factor IX was also
94 binds to a region of the phosphoenolpyruvate carboxykinase (GTP) (PEPCK) gene promoter adjacent to th
95 tor-I (NFI) binds to the phosphoenolpyruvate carboxykinase (GTP) (PEPCK) gene promoter immediately 5'
96 or the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) (PEPCK-C) (4.1.1.32) during diabetes
97 ne in which the cDNA for phosphoenolpyruvate carboxykinase (GTP) (PEPCK-C) (EC 4.1.1.32) was linked t
101 lucose-6-phosphatase and phosphoenolpyruvate carboxykinase in the leptin-infused fetuses were lower t
104 cript abundance of PHOSPHOENOLPYRUVATE (PEP) CARBOXYKINASE increased during fruit ripening and was ne
105 olinate, an inhibitor of phosphoenolpyruvate carboxykinase, indicating that it is not due to increase
107 he gluconeogenic enzyme, phosphoenolpyruvate carboxykinase-M (Pck2/PEPCK-M), increased during treatme
108 g protein (P-CREB), and phosphoenol pyruvate carboxykinase, markers of glucagon action, rose dramatic
111 creased, whereas that of phosphoenolpyruvate carboxykinase mRNA was increased compared with Leptin -.
112 ment binding protein and phosphoenolpyruvate carboxykinase mRNA were profoundly reduced compared with
113 iver pyruvate kinase and phosphoenolpyruvate carboxykinase mRNA were unchanged by the manipulation of
114 atic glucose production, phosphoenolpyruvate carboxykinase mRNA, and plasma FFA to a similar extent i
115 ally upregulated by HIF-1, including the PEP carboxykinase PCK-1, a rate-limiting mediator of glucone
116 oneogenic pathway enzyme phosphoenolpyruvate carboxykinase (Pck) also increased under these condition
117 lic enzyme (NADP-ME) and phosphoenolpyruvate carboxykinase (PCK) photosynthetic pathways was twofold
118 energy-conserving phosphoenolpyruvate (PEP) carboxykinase (pck), which normally functions in the rev
123 s between MDH2 and yeast phosphoenolpyruvate carboxykinase (PCK1) and between MDH2 and fructose-1,6-b
124 metabolism by targeting phosphoenolpyruvate carboxykinase (PCK1) and glucose-6-phosphatase (G6PC), k
125 tic gluconeogenic genes, phosphoenolpyruvate carboxykinase (PCK1) and glucose-6-phosphatase (G6PC).
126 6-phosphatase (G6PC) and phosphoenolpyruvate carboxykinase (PCK1) expression, key regulators of hepat
127 he activity of cytosolic phosphoenolpyruvate carboxykinase (PCK1), a key enzyme in gluconeogenesis, b
128 sites (Lys19 and 514) of phosphoenolpyruvate carboxykinase (Pck1p) were determined by tandem mass spe
129 beta-cell PKm1, PKm2, and mitochondrial PEP carboxykinase (PCK2) that generates mitochondrial PEP.
130 show that mitochondrial phosphoenolpyruvate carboxykinase (PCK2), the hub molecule linking tricarbox
133 -6-phosphatase (G6P) and phosphoenolpyruvate carboxykinase (PEPCK) activities were investigated in sh
135 significantly inhibited phosphoenolpyruvate carboxykinase (PEPCK) and accelerated fibroblast cell mi
136 glycogenolytic enzymes, phosphoenolpyruvate carboxykinase (Pepck) and glucose-6-phosphatase (G6p).
137 ed with normal levels of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase)
138 Hepatic gene expression of P-enolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (Glc-6-P
139 criptional expression of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase, catalyt
140 genic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase, leading
142 the gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK) and impairs insulin signalling in
143 e elements (IREs) of the phosphoenolpyruvate carboxykinase (PEPCK) and insulin-like growth factor-bin
144 decarboxylation enzymes phosphoenolpyruvate carboxykinase (PEPCK) and malic enzyme (ME) did not chan
145 he gluconeogenic enzymes phosphoenolpyruvate carboxykinase (PEPCK) and phosphoenolpyruvate carboxykin
146 t of decreased cytosolic phosphoenolpyruvate carboxykinase (PEPCK) and plastidic NADP-dependent malic
147 lation of Glc-6-Pase and phosphoenolpyruvate carboxykinase (PEPCK) by apoA-IV was determined by lucif
148 ng Leishmania glycosomal phosphoenolpyruvate carboxykinase (PEPCK) by EP and again found that the int
153 the gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK) demonstrate that PEPCK contains a
154 , we reveal two discrete phosphoenolpyruvate carboxykinase (PEPCK) enzymes in the parasite, one of wh
155 pendent assays: reducing phosphoenolpyruvate carboxykinase (PEPCK) expression in hepatocytes and acti
157 e change was evident for phosphoenolpyruvate carboxykinase (PEPCK) expression, pyruvate kinase expres
158 takes a fold similar to phosphoenolpyruvate carboxykinase (PEPCK) from Escherichia coli as recently
162 Transcription of the phosphoenolpyruvate carboxykinase (PEPCK) gene is induced by glucagon, actin
163 Transcription of the phosphoenolpyruvate carboxykinase (PEPCK) gene is induced upon activation of
164 Transcription of the phosphoenolpyruvate carboxykinase (PEPCK) gene is regulated by a variety of
165 mple by showing that the phosphoenolpyruvate carboxykinase (PEPCK) gene knockout ( pepck) leads to th
166 e element (RARE1) in the phosphoenolpyruvate carboxykinase (PEPCK) gene promoter confers approximatel
168 element (CRE) of the rat phosphoenolpyruvate carboxykinase (PEPCK) gene promoter is required for a co
169 rticoid induction of the phosphoenolpyruvate carboxykinase (PEPCK) gene requires a glucocorticoid res
170 rlying increased hepatic phosphoenolpyruvate carboxykinase (PEPCK) gene transcription and gluconeogen
171 pattern of induction of phosphoenolpyruvate carboxykinase (PEPCK) gene transcription by cAMP and its
173 fold increase in hepatic phosphoenolpyruvate carboxykinase (PEPCK) gene transcription through two low
175 mice overexpressing the phosphoenolpyruvate carboxykinase (PEPCK) gene under control of its own prom
176 of transcription of the phosphoenolpyruvate carboxykinase (PEPCK) gene, which encodes a key gluconeo
179 ne the role of cytosolic phosphoenolpyruvate carboxykinase (PEPCK) in hepatic energy metabolism.
180 hrough downregulation of phosphoenolpyruvate carboxykinase (PEPCK) in wild-type (WT) mouse liver.
181 n of Akt, which inhibits phosphoenolpyruvate carboxykinase (PEPCK) induction, causing severe hypoglyc
183 gene encoding cytosolic phosphoenolpyruvate carboxykinase (PEPCK) is a PPARgamma/RXR target gene in
189 cription of the gene for phosphoenolpyruvate carboxykinase (PEPCK) is stimulated by thyroid hormone (
191 d receptor (GR) mRNA and phosphoenolpyruvate carboxykinase (PEPCK) mRNA (and activity) are increased
193 ne present in the enzyme phosphoenolpyruvate carboxykinase (PEPCK) of the organisms Caenorhabditis el
194 rabbit CRP from the rat phosphoenolpyruvate carboxykinase (PEPCK) promoter in response to gluconeoge
195 elial cells, we used the phosphoenolpyruvate carboxykinase (PEPCK) promoter to generate transgenic mi
197 se sequence (IRS) of the phosphoenolpyruvate carboxykinase (PEPCK) promoter, located within the gluco
198 under the control of the phosphoenolpyruvate carboxykinase (PEPCK) promoter, were developed as an app
199 ession was driven by the phosphoenolpyruvate carboxykinase (PEPCK) promoter, which gives high level e
200 he reaction catalyzed by phosphoenolpyruvate carboxykinase (PEPCK) provides significant insight into
201 rat cytosolic isoform of phosphoenolpyruvate carboxykinase (PEPCK) reported in the PEPCK-Mn2+, -Mn2+-
203 hosphatase (Glc-6-P) and phosphoenolpyruvate carboxykinase (Pepck) to an extent similar to both AICAR
204 ort gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK) transcription and associated trans
205 Avian mitochondrial phosphoenolpyruvate carboxykinase (PEPCK) was incubated with Co2+ and H2O2 t
207 ures of the human enzyme phosphoenolpyruvate carboxykinase (PEPCK) with and without bound substrates.
208 sion of transcription of phosphoenolpyruvate carboxykinase (PEPCK), a key regulator of gluconeogenesi
210 We provide evidence that phosphoenolpyruvate carboxykinase (PEPCK), an enzyme involved in malate meta
211 key gluconeogenic genes, phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase (G6Pase
212 tivator-1 alpha (PGC-1), phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase express
213 of glycerol kinase (GK), phosphoenolpyruvate carboxykinase (PEPCK), and pyruvate phosphate dikinase (
214 4-(13)C]oxaloacetate via phosphoenolpyruvate carboxykinase (PEPCK), forward TCA cycle flux of [4-(13)
215 8 and increase levels of phosphoenolpyruvate carboxykinase (PEPCK), glucose-6-phosphatase, and peroxi
216 ey gluconeogenic enzyme, phosphoenolpyruvate carboxykinase (PEPCK), has been shown to provide metabol
217 ponsive sequences of the phosphoenolpyruvate carboxykinase (PEPCK), IGFBP-1, and G6Pase promoters.
218 tivator-1a (PGC-1alpha), phosphoenolpyruvate carboxykinase (PEPCK), pyruvate carboxylase, and glucose
220 nduction of the gene for phosphoenolpyruvate carboxykinase (PEPCK), the rate-limiting enzyme in gluco
222 6-phosphatase (G6PC) and phosphoenolpyruvate carboxykinase (Pepck), two gluconeogenetic genes, along
244 ly identified Leishmania phosphoenolpyruvate carboxykinase (PEPCK, a gluconeogenic enzyme) as an immu
246 he cytosolic form of the phosphoenolpyruvate carboxykinase (PEPCK-C) gene is selectively expressed in
247 mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) is the GTPase linking hydrolysis
249 files of selected genes (phosphoenolpyruvate carboxykinase - PEPCK, glucocorticoid receptor - GR, and
251 , a classic inhibitor of phosphoenolpyruvate carboxykinase, photosynthetic O(2) evolution was reduced
252 lucose-6-phosphatase and phosphoenolpyruvate carboxykinase, presumably, because of relative intrahepa
253 enolpyruvate carboxylase/phosphoenolpyruvate carboxykinase process that decreases as the parasite mat
254 F1-CRP) regulated by the phosphoenolpyruvate carboxykinase promoter such that levels could be altered
256 mice that expressed the phosphoenolpyruvate carboxykinase promoter-driven BMP-7 transgene and nondia
258 he reaction catalyzed by phosphoenolpyruvate carboxykinase provide direct structural evidence for the
259 under control of the rat phosphoenolpyruvate carboxykinase regulatory sequences developed fibrosis of
260 cohol dehydrogenase, and phosphoenolpyruvate carboxykinase) that indicate the potential mechanisms co
261 cycle first and then use phosphoenolpyruvate carboxykinase to initiate gluconeogenesis; and (v) (13)C
262 veral HNF3 target genes (phosphoenolpyruvate carboxykinase, transferrin, tyrosine aminotransferase) w
263 lucose-6-phosphatase and phosphoenolpyruvate carboxykinase, two key targets for FoxO1 in the regulati
264 n such as those encoding phosphoenolpyruvate carboxykinase, tyrosine aminotransferase, and insulin-li
265 -inducible genes such as phosphoenolpyruvate carboxykinase was maintained when cellular protein synth
266 ralobular distribution of phosphenolpyruvate carboxykinase was unaltered, though overall increased ac
267 cohol dehydrogenase, and phosphoenolpyruvate carboxykinase, was also affected in some of the microcel
268 ic and the mitochondrial phosphoenolpyruvate carboxykinase were elevated after 24 hours of NMP, more
269 s (NADP-malic enzyme and phosphoenolpyruvate carboxykinase) were critical for matching ATP and reduce
270 es, isocitrate lyase and phosphoenolpyruvate carboxykinase, were also degraded in the vacuole via the
271 esis controller, hepatic phosphoenolpyruvate carboxykinase, were significantly elevated in response t
272 st gluconeogenic enzyme, phosphoenolpyruvate carboxykinase, when acetate was the carbon source, sugge
273 the citric acid cycle intermediates via PEP carboxykinase, whereas another could involve reversal of